DERMAHAN V10 WHITENING TONE UpCREAM

Manufacturer
LAON COMMERCE co ltd
Effective date
2023-03-06
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 23:54:24

Label at a glance#

ProductDERMAHAN V10 WHITENING TONE UpCREAM
Active ingredientADENOSINE, NIACINAMIDE
Label structure8 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Adenosine, Niacinamide

INACTIVE INGREDIENT SECTION

Water
Butylene Glycol
Glycerin
Dimethicone
Titanium Dioxide
Cyclopentasiloxane
Panthenol
Sodium Acrylate/Sodium Acryloyldimethyl Taurate Copolymer
Trisiloxane
Dicaprylyl Carbonate
Isohexadecane
Dimethiconol
Silica
Sodium Polyacrylate
Benzyl Glycol
Ethylhexyl Stearate
Polysorbate 80
Ethylhexylglycerin
Triethoxycaprylylsilane
Aluminum Hydroxide
Allantoin
Trideceth-6
Citrus Aurantium Dulcis (Orange) Peel Oil
Sorbitan Oleate
Disodium EDTA
C11-13 Isoalkane
Litsea Cubeba Fruit Oil
Hydrogenated Lecithin
Polyglyceryl-10 Stearate
Tocopheryl Acetate
Sodium Ascorbyl Phosphate
Glyceryl Arachidonate
Glyceryl Linolenate
Pyridoxine
Folic Acid
Thiamine HCl
Biotin
Retinyl Palmitate
Cyanocobalamin
Limonene
Citral

OTC - PURPOSE SECTION

whitening, wrinkle care

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

KEEP OUT OF REACH OF THE CHILDREN

INDICATIONS & USAGE SECTION

Take an appropriate amount of this product and spread it evenly on the skin

WARNINGS SECTION

1. Consult a specialist, if there are abnormal symptoms or side effects such us red spots, swelling, or itching in the area of use due to direct sunlight when using or after using cosmetics.

2. Refrain from using on area s with wounds.

3. Precaution for storage and handling a) Keep out of reach of children b) Store away from direct sunlight

DOSAGE & ADMINISTRATION SECTION

topical use only

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

labellabel

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
ADENOSINE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
d676a241-be05-4740-b3ee-1a5f2ed422d2Product name420180615
dd8bd48f-20d6-43c7-b471-3ae872868afaProduct name320180125
d41954ff-bc63-4b2c-aba0-9146707659d7Product name220151117

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
82083-0014-1DERMAHAN V10 WHITENING TONE UpCREAM50 mL in 1 TUBECREAM501

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
82083-0014DERMAHAN V10 WHITENING TONE UPCREAM (ADENOSINE, NIACINAMIDE) CREAM [LAON COMMERCE CO LTD]1Current NDC, 1 package rows20230308_f644b6bf-e511-196f-e053-2a95a90a13b1.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 5 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
82083-001482083-0014-1

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 3 matching rows.

Name, UNII, Kind table
NameUNIIKind
WATER059QF0KO0RIACT
ADENOSINEK72T3FS567ACTIB
NIACINAMIDE25X51I8RD4ACTIB

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
DERMAHAN V10 WHITENING TONE UpCREAMADENOSINE, NIACINAMIDELAON COMMERCE co ltdf644b6bf-e511-196f-e053-2a95a90a13b12023-03-06WarningsExact identifier
ndc (package): 82083-0014-1
ndc (product): 82083-0014
ndc11 (package): 82083001401
spl id: f644c802-85aa-73d4-e053-2a95a90ac4e6
spl set id: f644b6bf-e511-196f-e053-2a95a90a13b1

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.